ArticleBMC plant biology2026
Functional study and sequence variation of the SrUGT85C2 genes in Stevia rebaudiana.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Stevia rebaudiana Bertoni is recognized as the third major source of natural sweetness due to its leaves being rich in high-sweetness, low-calorie steviol glycosides (SGs). A crucial enzyme in the metabolic glycosylation grid of SGs, uridine diphosphate glycosyltransferase SrUGT85C2 catalyzes the glycosylation of the C13-hydroxyl of the steviol, creating a β-D-glucoside link and 13-steviol monoside. However, the key residues of the SrUGT85C2 enzyme and how SrUGT85C2 affects the accumulation of SGs in S. rebaudiana remain unclear. In this study, cloning and functional analysis of SrUGT85C2 gene sequences were performed in 10 different S. rebaudiana genotypes with divergent SG compositions. After sequences analysis, eleven variants of this gene were identified. The mutants N05-5 and N02-6, for which no catalytic function was detected, caused changes in substrate binding and pocket conformation due to single amino acid substitutions, thereby hindering the approach of the reaction group. Molecular docking analysis suggested that mutants N02-1, N02-5 and 023 − 3 increase the efficiency of steviol conversion, potentially by forming additional hydrogen bonds. Because steviol-19-O-glucoside (19-SMG) and UDP-glucose (UDPG) overlap spatially, mutants 11-14-5 and N01-1 prevent C19-glycosylation. Molecular docking-based site-directed mutagenesis verified that steviol and 19-SMG catalytic activity were enhanced by the mutant proteins K25H and E418G to 164.1% and 203.6% of the SrUGT85C2 protein, respectively. In addition, the expression analysis of SrUGT85C2 in each genotypes showed that the expression levels of the gene varied significantly among genotypes, with high expression observed in GP. K25 and E418 were also found to be effective positive mutation sites for SrUGT85C2 in this work, offering a theoretical foundation for the production of premium S. rebaudiana materials and the effective microbial synthesis of optimal steviol glycosides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.